One-Alpha
One-Alpha

0.62
Assists in the vital mineralization of skeletal structures and fortifies bone density for Bone Health by promoting intestinal calcium absorption to elevate systemic mineral levels.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Alfacalcidol
Reference Brand
One-Alpha
Product Origin
Generic Alternative
Reference Manufacturer
Leo Pharma
Product Form
Capsule, Drops
Regulatory Classification
Rx
Primary Category
Bone Health
Product Category
Vitamin D analogue
Pharmacological Class
Vitamin D derivative
Clinical Indications
Osteoporosis, Hypocalcaemia
Manufacturer Description
Indicated to support bone health by regulating calcium and phosphate levels, intending to mitigate the risk of bone loss and related disorders.
Mechanism of Action
Works as an active form of Vitamin D that assists the body in absorbing calcium and phosphate for healthy bone development.
Route of Administration
Oral
Onset Time
Hours
Duration
24 hours
Contraindications
Hypercalcemia
Severe Adverse Events
Kidney stones
Common Side Effects
Nausea
Uncommon Side Effects
High calcium levels
Drug Interactions
Diuretics
Pregnancy Safety Warnings
Use under supervision.
Storage Guidelines
Store at room temperature.
Related Products
Calcitriol

One-Alpha FAQ

How do digital health platforms or telehealth services facilitate evaluation and access to One-Alpha in Singapore?

Digital health platforms connect patients with healthcare professionals who facilitate an assessment of bone health. This process ensures that individuals receive a review of their condition before accessing One-Alpha, prioritizing compliance with professional medical guidance.

Why are there cost variations between multi-source generic Alfacalcidol formulations and originator brands?

Economic factors, including manufacturing overhead, quality assurance, and market distribution strategies, influence cost. Generic formulations like One-Alpha are designed to provide bioequivalent options that offer comparable therapeutic impact while focusing on efficient production and distribution.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories or platforms providing Alfacalcidol?

Verification necessitates checking that the platform operates within the legal framework for Prescription-Only Medicines. Patients should look for clarity on sourcing, the integration of professional oversight, and clear guidance on how the distribution process aligns with local health authority standards.

What are the logistical or regulatory considerations when utilizing cross-border facilitation or importing One-Alpha into Singapore for personal use?

Importing medicinal compounds across international borders involves stringent checks by regulatory agencies. Ensuring the legitimacy of the product and adhering to Singaporean health regulations regarding the personal import of therapeutic substances remains essential to avoid breaches in logistical compliance.

How is One-Alpha framed in terms of clinical bioequivalence when considering generic Alfacalcidol alternatives?

One-Alpha is classified as a bioequivalent generic formulation, meaning it has demonstrated the same clinical performance and physiological effect as reference standards. Clinical assessments treat such formulations as interchangeable regarding their ability to manage conditions, provided the dosage remains identical according to professional instruction.

What is Alfacalcidol?

Facilitating calcium homeostasis, Alfacalcidol functions as a synthetic vitamin D analogue derived from the chemical structure of ergocalciferol. Medical practitioners support patients within the bone health category by utilizing this compound to modulate mineral metabolism.

Regulation of metabolic pathways in the body remains the primary therapeutic intent for this compound. Biological systems rely on the activation of this substance to encourage proper mineral uptake in skeletal tissues.

Regulatory & Classification Profile

Singapore regulatory frameworks classify Alfacalcidol as a Prescription-Only Medicine (POM). Access to this therapeutic agent requires a formal evaluation through healthcare channels within the local medical landscape to ensure patient safety and clinical appropriateness.

Formulations & Associated Medications

One-Alpha functions as a bioequivalent generic formulation containing the active ingredient Alfacalcidol. Available formulations accessible through our website include One-Alpha cap in strengths of 0.25mcg.

Therapeutic Applications

  • Manages hypocalcemia in patients with chronic renal insufficiency.
  • Addresses symptoms of renal osteodystrophy to support skeletal integrity.
  • Manages secondary hyperparathyroidism by suppressing excess parathyroid hormone production.
  • Supports calcium absorption pathways in individuals with specific metabolic bone health concerns.

Biological Action

Alfacalcidol undergoes conversion in the liver to generate a form of vitamin D that exerts influence over tissues involved in mineral regulation. Increased absorption of calcium and phosphate from the digestive tract occurs following systemic distribution. Skeletal maturation and tissue density stability remain the primary areas of influence for this physiological process.

Treatment Landscape & Drug Class

Alfacalcidol belongs to the vitamin D analogue class of therapeutic agents. Modern protocols utilize these compounds to bridge the gap in metabolic function when physiological systems fail to synthesize sufficient quantities of endogenous vitamin D.

Understanding the Safety Profile

Physiological involvement of Alfacalcidol extends through the renal and gastrointestinal systems, where it modulates the balance of calcium levels in the bloodstream. Maintaining equilibrium requires precise monitoring to ensure systemic stability. Excessive accumulation within the system can impact organ function, particularly affecting renal or cardiovascular tissues if levels exceed standard ranges. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Alfacalcidol serves as an educational focus for individuals managing specific bone health conditions. Medicines like One-Alpha differ in strength based on formulation, necessitating precise observation of the provided dosage. Medical history and individual risk factors must remain the priority when evaluating suitability for this treatment. Consult with a qualified healthcare professional regarding personal health needs and reviewing the labeling provided with any preparation to ensure proper use, as no singular approach applies to all users.

Clinical Glossary

Alfacalcidol
A synthetic form of vitamin D that requires hepatic metabolism to reach functional activity.
Hypocalcemia
A medical state characterized by low calcium levels in the serum, often necessitating supplemental management.
Hyperparathyroidism
A condition where the parathyroid glands release excess hormones, often triggering negative impacts on bone density.
Renal Osteodystrophy
A bone disease resulting from the failure of the kidneys to maintain proper mineral levels in the blood.
Information associated with One-Alpha is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories